INTRODUCTION {#SEC1}
============

Drug discovery has witnessed a paradigm shift from the traditional *one drug-one target* view to the multi-target approach, creating a need for novel computational tools that could aid in polypharmacological studies. Polypharmacology refers to the ability of a drug molecule to interact with multiple targets simultaneously ([@B1],[@B2]). Such promiscuous drug-target interactions may lead to both therapeutic effects and off-target side effects. Recent efforts in drug discovery have made use of polypharmacology as a means of repurposing or repositioning approved drugs for novel disease targets ([@B3]), which in-turn may significantly reduce both the economic cost and time invested in drug development process ([@B4],[@B5]). Polypharmacology can also help to design *selectively promiscuous* drugs, such as multi-kinase anti-cancer agents ([@B2],[@B6]). Furthermore, polypharmacology is being used to identify and explain the off-target activities of drugs that result in harmful side-effects, thereby assisting in compound optimization applications ([@B7]). The existing computational approaches for investigating polypharmacological effects and predicting drug-target interactions can be broadly categorized as *target-centric* ([@B8],[@B9]) or *compound-centric* ([@B10],[@B11]). The underlying hypothesis in the target-centric approaches is that structurally similar targets are expected to have similar selectivity properties, and hence are likely to bind the same compound. Therefore, this approach is useful for target-based drug discovery approach, although it is applicable only to targets whose structural information is available. The compound or *chemo-centric* approach is based on the principle that structurally similar compounds tend to bind to the same targets; therefore, this approach is best-suited for identifying compound analogs, hence supporting the phenotype-based and polypharmacology paradigm of drug discovery.

Chemoinformatic web-applications have been developed for target-centric visualization of broad spectrum activity of compounds against well-studied protein families such as kinases; e.g. Kinome Render ([@B12]), TREEspot and KinMap ([@B13]). For the compound-centric analyses, similar easy-to-use web-tools are not available, although the computational protocol to estimate compound similarities has been detailed by Vilar *et al.* ([@B14]). Most of the existing tools to analyze drug screening assays through clustering and visualization of compounds and their corresponding bioactivity measurements have been implemented as stand-alone tools requiring local installation, e.g. Scaffold Hunter ([@B15]), ChemTreeMap ([@B16]), Mona 2 ([@B17]) and Data warrior ([@B18]) or as a browser-based tool, e.g. ChemMineTools ([@B19]). However, most tools assume the users to have chemoinformatics and database management skills (MySQL), and either require the structure of the compounds or their PubChem compound identifiers as a primary input ([@B20]). Furthermore, even though the existing tools can address a broad range of questions arising in drug discovery applications, they often lack an interactive interface and other user options required by a chemical biologist for real-time sharing, visualization and interpretation of bioactivity data from drug screening assays. To address these limitations, we have capitalized on recent developments in server management and Data Object Model (DOM) frameworks, and implemented a fully-automated, open-source web-based application, named Compound SPecific bioActivity DEndrogram (C-SPADE), which enables biologists with little to no informatics skills to interactively visualize, annotate and investigate the relationships between the compounds' structural similarities and phenotypic responses through compound-centric bioactivity clustering.

MATERIALS AND METHODS {#SEC2}
=====================

Implementation {#SEC2-1}
--------------

C-SPADE web-application adapts a client-server model (Figure [1](#F1){ref-type="fig"}), in which session management is maintained through Python Django (version 1.9), and the server-side computation is implemented using Python (version 2.7). The compound names in the input screening data are automatically queried against the PubChem database ([@B21]) to retrieve structural description as SMILES. The user can also directly upload the SMILES information of the compounds, which is useful especially when multiple custom structures are used as input. The input data is later displayed on the *Data Preview* page. C-SPADE utilizes the RDKit python module (version 2016.09.1) to calculate various compound fingerprints (FPs) and their similarities. With the MACCS and Daylight FPs, the structural similarity is calculated using Tanimoto similarity ([@B22]), whereas with Atom-pair and Morgan (ECFP-like) FPs using Dice similarity ([@B23]) coefficient. The Scipy module (version 0.13.2) then constructs an agglomerative hierarchical cluster using the compound similarities, where the linkage distance between clusters are estimated using the Ward minimum variance method. The resulting compound dendrogram is annotated with bioactivity values and saved as a JavaScript Object Notation (JSON) file for client input. The client-side uses DOM implemented through D3 JavaScript library (<http://d3js.org/>), HTML5 Canvas and CSS for the interactive analysis and visualization of the compound similarity dendrogram. C-SPADE has been checked for compatibility with all standard modern browsers (Mozilla Firefox, Google Chrome and Safari) and operating systems (Windows, MacOSX and various Linux distributions).

![An infographic illustration of C-SPADE web-tool and its functionalities. (**A**) Various types of biological drug screening assays (biochemical, cell-based, cell-free or target-based assays) can be analyzed. (**B**) The key functionalities implemented in C-SPADE. (**C**) The input consists of a tab-delimited text file of drug screening data, with compound names and bioactivity values, where a wide range of activity measurements are supported. (**D**) On the server-side, the compound name is used to retrieve the compound structural information from the PubChem database and various compound features are calculated using the RDKit package. (**E**) The client-side options provide an interactive interface to visualize and customize the compound clusters. (**F**) The output visualization from C-SPADE can be either shared with collaborators or downloaded as publication-quality images or as a Newick tree file.](gkx384fig1){#F1}

Session management {#SEC2-2}
------------------

C-SPADE enables the analysis of multiple inputs simultaneously and displays each submission in a separate row on the *My Projects* page, providing links to *Data Preview* page and *Visualization* page as icons that are color-coded based on the status of data processing. The link to *Visualization* page is not available until the user invokes it from the *Data Preview* page, which serves as a check to ensure that the user has verified the automatically-retrieved information. The user can either bookmark the web address or save the workspace to enable saving and processing the results at a later time. Each user session is managed anonymously and has an expiration period of 10 days, providing the user sufficient time to analyze the output. C-SPADE visualization has been designed for low-throughput studies; a profiling data of ∼500 compounds takes less than 6 min to process and visualize. Larger datasets (\>600 compounds), although computationally more intensive and time consuming, can still be processed, and the user can retrieve the compound similarity dendrogram as a Newick tree file for further analyses.

Input format {#SEC2-3}
------------

C-SPADE currently accepts a tab-delimited text file (.txt) of a preprocessed drug screening data as input. The input file should include the following columns: *Compound* (required), the unique names of the compounds used in the screen; *Smiles* (optional), the compounds whose SMILES information is provided will be directly used by C-SPADE to calculate their structural features; otherwise, the compound names will be queried against the PubChem database to retrieve the SMILES; one or more screening assays (optional) (i.e. protein targets, cell lines, patient samples, etc.), each assay in a separate column providing numerical bioactivity values (e.g., IC~50~, EC~50~, *K*~i~, *K*~d~, area under the dose response curve (AUC) or drug sensitivity score (DSS) ([@B24])); *Annotation* (optional), additional annotations of the compounds (e.g. compound class, compound properties, etc.), if available.

Compound selection {#SEC2-4}
------------------

The *Data Preview* page allows the user to edit, curate and select a subset of data for visualization. Compounds whose SMILES are either provided by user or retrieved from PubChem are automatically selected for the visualization. The PubChem compound identifiers (CID) in the *Data Preview* page are hyperlinked to the PubChem database, giving the user the possibility to check the retrieved compound\'s information. The user can visualize the chemical diversity of a subset of compounds from the screening panel by selecting the compounds using the check boxes located at the beginning of each row in the table (note: a minimum of 10 compounds are required to generate the clustering dendrogram). Through the *Add Compounds* option, C-SPADE facilitates on-the-fly similarity investigation, where the similarity of one or more investigational molecules to the drugs in the screening panel can be visualized. Selecting this option adds a new row in the table, where the user is expected to provide the name of the compound and its structural information as SMILES. These compounds can be clustered and visualized with the selected compounds in the table using the *Visualize* option.

Cluster visualization {#SEC2-5}
---------------------

Similar to a traditional phylogenetic tree, the main visual interface in C-SPADE displays the chemical space of compounds used in the screen as a hierarchically-clustered dendrogram, where each compound forms the node in the tree annotated with their respective bioactivity values as bubbles (Figure [2A](#F2){ref-type="fig"}). Currently, C-SPADE uses molecular fingerprints as features to measure the compound similarity; the closer two compounds are in the tree, the higher is their chemical similarity in terms of their similarity coefficient. The bioactivity values from individual screens of each compound are categorized into five potency classes using log-transformed IC~50~, EC~50~, *K*~i~, *K*~d~ values (≤1 nM, ≤10 nM, ≤100 nM, ≤1 uM, ≤10 uM) and displayed in the dendrogram. With the summary measurements, such as AUC and DSS, the actual bioactivity values are used and represented as circular annotations in the dendrogram. Visual key for the bioactivity values, activity classes, and compound annotations are shown in the legend of the dendrogram to interpret the output visualization (Figure [2B](#F2){ref-type="fig"}).

![(**A**) Compound-centric bioactivity dendrogram visualization of the example drug screening data ([@B25]). The drug panel contained a total of 250 compounds screened across three cytarabine-resistant SHI-1 cell-line variants (Parental, 320 Ara-C and 1280 Ara-C) to identify drugs that could counteract cytarabine resistance. A subset of 75 compounds were selected and their chemical space was visualized using the C-SPADE web-tool. The nodes are the compounds and the distance between the nodes represents the degree of their structural similarity based on the selected ECFP4 fingerprints. The bioactivity measurements (DSS) of each compound are represented as circles, where the radius of the circle is proportional to the bioactivity level. *Inset:* the distinct sub-clusters of glucocorticoids (**d**) and nucleoside analogues (**e**). (**B**) The provided bioactivities, activity classes and compound annotations, if available, are color-coded and displayed in the legend. (**C**) The types of dendrogram layouts and styles that are currently available in C-SPADE. The glucocorticoids (**D**) showed an increased sensitivity in the cytarabine resistant cell-lines, whereas the nucleoside analogues (**E**) showed a co-resistance pattern in the cytarabine resistant SHI-1 cells. In this example, C-SPADE enables the user to (i) map the chemical space of the compounds screened, (ii) explain the sub-clustering patterns that one commonly encounters in such drug-screening data analysis, and (iii) investigate and predict structurally similar compounds that cluster into a desired activity cluster prior to a future compound screening application.](gkx384fig2){#F2}

Interactive options {#SEC2-6}
-------------------

C-SPADE serves as an exploratory tool and provides a highly interactive and customizable visual workspace. For instance, the user has the options to upload multiple datasets, and in real-time change the molecular features for calculating the compound similarity clusters. The visual workspace that displays the compound dendrogram provides several options in the sidebar to interactively customize the visualization. The layout of the displayed dendrogram can be altered between a tree and radial layout (Figure [2C](#F2){ref-type="fig"}). Features corresponding to the branches and nodes of the tree, such as thickness, radius and colors, can also be dynamically changed. The font sizes of compound labels and annotations are adjustable. Color coding of different assay classes and compound annotations can be interactively changed, and these changes are simultaneously updated in the figure legend. In addition to the traditional zoom and pan functions, C-SPADE provides also other toolbar options, such as a search bar to search and highlight a compound in the tree and rotate option to rotate a radial tree to any given angle. Hovering the mouse pointer over a bioactivity bubble or a compound name displays a tooltip that shows the input bioactivity value or structure of the compound, respectively. The *Save Workspace* option saves the last performed changes by the user in the visual workspace, hence providing the most updated version of the visualization when revisited.

Output formats {#SEC2-7}
--------------

Once customized, the compound clustering can be downloaded either as Portable Network Graphics image (.png) or as a Portable Document Format file (.pdf). The web-tool enables background transparency and maintains a high degree of spatial resolution for these outputs files, thereby generating publication-ready figures. The user can also choose to download the compound similarity dendrogram in a Newick file format (.nwk) to post-process the hierarchical tree object independent of the C-SPADE. By using the *Share* option, the user can share the hyperlink to the visual workspace, providing the possibility for collaborators to visualize and customize the results interactively.

Documentation and example data {#SEC2-8}
------------------------------

To enable easy start, we have provided an extensive documentation in the help section that explains all the features of C-SPADE in detail. For testing the web-tool we also provide an example data in the form a preprocessed subset of bioactivity data from a cell-based drug screening assay by Malani *et al*. ([@B25]). This example dataset contains 75 compounds screened across three cell-types (Figure [2A](#F2){ref-type="fig"}), using DSS as the bioactivity measure, and with a subset of compounds annotated by the inhibitor type (Figure [2D](#F2){ref-type="fig"} and [E](#F2){ref-type="fig"}) (e.g. glucocorticoids (Figure [2D](#F2){ref-type="fig"}), nucleoside analogue (Figure [2E](#F2){ref-type="fig"}), anti-metabolite, etc.). For templates of the input data, the user can download this example data in various formats. We have also implemented a quick tutorial section to help the users to quickly go through C-SPADE\'s functionalities (available at <http://cspade.fimm.fi/>).

CONCLUSION AND FUTURE WORK {#SEC3}
==========================

We have implemented C-SPADE, a secure web-based application that enables the users to interactively map and explore drug screening data. Through constructing and visualizing compound-specific dendrograms, C-SPADE, provides a timely solution to the critical need for an efficient and easy-to-use compound-centric visualization tool, hence facilitating chemical biology researchers in various phenotypic screening and polypharmacology-based drug discovery applications. By merely requiring the compound names (and no structural information), C-SPADE serves as a *one click* tool, thereby significantly reducing the time needed from drug screening to data analysis and interpretation. The web-tool was designed mainly for the needs of biologist; to understand the diversity of the screening panel, to explore investigational compounds' similarity to the screening panel, and for polypharmacological explorations. However, C-SPADE may also aid chemo-informaticians to draw conclusions related to drug-target interaction predictions. When compared with the traditional heat-map visualization of drug screening data, C-SPADE, through its compound-specific clustering, provides a novel perspective to analyze drug screening data.

Like any other browser-based application, C-SPADE is limited by the size of the data that can be processed and visualized. The current version of C-SPADE uses standard fingerprint measurements from SMILES as compound features, and one future improvement will be to incorporate 2D and 3D molecular descriptor information in feature calculation. The next version of C-SPADE will incorporate also sub-cluster analysis and implement the Maximum Common Substructure ([@B26]) algorithm to aid users in compound-optimization studies.
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